4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000950170-23-065868
Chief Legal Officer sold 10,000 shares at an average $30.50 ($305,000)
- Chief Legal Officer acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bellon Christine Chief Legal Officer | 2023-11-20 | Option exercise 10b5-1 | +4,182 | $7.22 | $30,194 | 86,584 | D |
| Bellon Christine Chief Legal Officer | 2023-11-20 | Option exercise 10b5-1 | +5,818 | $7.22 | $42,006 | 92,402 | D |
| Bellon Christine Chief Legal Officer | 2023-11-20 | Sale 10b5-1 | −5,000 | $30.00 | $150,000 | 87,402 | D |
| Bellon Christine Chief Legal Officer | 2023-11-20 | Sale 10b5-1 | −5,000 | $31.00 | $155,000 | 82,402 | D |
| Derivatives | |||||||
| Bellon Christine Chief Legal Officer | 2023-11-20 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,182 | 9,492 | D | ||
| Bellon Christine Chief Legal Officer | 2023-11-20 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,818 | 10,918 | D | ||
| Open-market sales · 10,000 sh · avg $30.50 · $305,000 | |||||||
Loading xslF345X05/ownership.xml…